Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CAPR
Stock Latest News
Market News
CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics
7d ago
CAPR
Premium
Company Announcements
Capricor Therapeutics Faces Challenges Despite Strong Cash Position
8d ago
CAPR
Premium
Ratings
Capricor Therapeutics: Promising Developments in Exosome-Based Vaccine and Strategic Engagements with FDA
22d ago
CAPR
Premium
The Fly
Capricor announces first subjects dosed in Phase 1 trial of StealthX
22d ago
CAPR
Premium
Ratings
Optimistic Buy Rating for Capricor Therapeutics Amid Regulatory Challenges and Strategic Alignments
27d ago
CAPR
Premium
Ratings
Capricor Therapeutics: Strong Financial Position and Strategic Initiatives Drive Buy Rating Despite Regulatory Challenges
28d ago
CAPR
Premium
Company Announcements
Capricor Therapeutics: Q2 2025 Financial and Strategic Update
28d ago
CAPR
Premium
The Fly
Capricor Therapeutics reports Q2 EPS (57c), consensus (48c)
28d ago
CAPR
Premium
The Fly
Capricor Therapeutics options imply 14.8% move in share price post-earnings
28d ago
CAPR
Premium
The Fly
Video: Nvidia, AMD said to pay U.S. 15% of revenue from China chip sales
29d ago
WU
ALB
Premium
Pre-Earnings
Capricor Therapeutics, Inc. (CAPR) Q2 Earnings Cheat Sheet
29d ago
CAPR
Premium
The Fly
Vinay Prasad returns to FDA as head of CBER
1M ago
CAPR
MGTX
Premium
The Fly
Capricor Therapeutics announces Type A meeting scheduled with U.S. FDA
1M ago
CAPR
Premium
The Fly
Capricor Therapeutics call volume above normal and directionally bullish
1M ago
CAPR
Premium
The Fly
Biotech stocks rise following Prasad exit from FDA
1M ago
BHVN
CAPR
Premium
Ratings
Capricor Therapeutics: Strategic Refinement and Optimism for Deramiocel’s FDA Approval
1M ago
CAPR
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
VG
CAN
Premium
Class Action
Capricor’s Trial Data Deception Triggers Major Lawsuit
2M ago
CAPR
Premium
Ratings
Positive Outlook on Capricor Therapeutics Despite Regulatory Setbacks
2M ago
CAPR
Premium
The Fly
Capricor Therapeutics price target lowered to $12 from $31 at Roth Capital
2M ago
CAPR
Premium
The Fly
Capricor Therapeutics price target lowered to $16 from $20 at Alliance Global
2M ago
CAPR
Premium
Market News
Capricor Therapeutics Stock (CAPR) Plummets 40% on FDA Rejection
2M ago
CAPR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
